HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1.

Abstract
The t(1;19) translocation of pre-B cell acute lymphocytic leukemia (ALL) produces E2a-Pbx1, a chimeric oncoprotein containing the transactivation domains of E2a joined to the homeodomain protein, Pbx1. E2a-Pbx1 causes T cell and myeloid leukemia in mice, blocks differentiation of cultured myeloid progenitors, and transforms fibroblasts through a mechanism accompanied by aberrant expression of tissue-specific and developmentally-regulated genes. Here we investigate whether aberrant gene expression also occurs specifically in the t(1;19)-containing subset of pre-B cell ALL in man. Two new genes, EB-1 and EB-2, as well as Caldesmon were transcriptionally activated in each of seven t(1;19) cell lines. EB-1 expression was extremely low in marrow from patients having pre-B ALL not associated with the t(1;19), and elevated more than 100-fold in marrow from patients with pre-B ALL associated with the t(1;19). Normal EB-1 expression was strong in brain and testis, the same tissues exhibiting the highest levels of PBX1 expression. EB-1 encodes a signaling protein containing a phosphotyrosine binding domain homologous to that of dNumb developmental regulators and two SAM domains homologous to those in the C-terminal tail of Eph receptor tyrosine kinases. We conclude that aberrant expression of tissue-specific genes is a characteristic of t(1;19) pre-B ALL, as was previously found in fibroblasts transformed by E2a-Pbx1. Potentially, EB-1 overexpression could interfere with normal signaling controlling proliferation or differentiation.
AuthorsX Fu, S McGrath, M Pasillas, S Nakazawa, M P Kamps
JournalOncogene (Oncogene) Vol. 18 Issue 35 Pg. 4920-9 (Sep 02 1999) ISSN: 0950-9232 [Print] England
PMID10490826 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Adenomatous Polyposis Coli Protein
  • Cytoskeletal Proteins
  • Homeodomain Proteins
  • Neoplasm Proteins
  • Oncogene Proteins, Fusion
  • RNA, Messenger
  • E2A-Pbx1 fusion protein
  • Phosphotyrosine
  • Protein-Tyrosine Kinases
Topics
  • Adenomatous Polyposis Coli Protein
  • Amino Acid Sequence
  • B-Lymphocytes (enzymology, metabolism, pathology)
  • Bone Marrow Cells (metabolism)
  • Cell Line
  • Cell Transformation, Neoplastic (genetics, pathology)
  • Cytoskeletal Proteins (chemistry, genetics)
  • Expressed Sequence Tags
  • Fetus (metabolism)
  • Gene Expression Regulation, Neoplastic
  • Homeodomain Proteins (genetics)
  • Humans
  • Molecular Sequence Data
  • Neoplasm Proteins (analysis, genetics)
  • Oncogene Proteins, Fusion (genetics)
  • Organ Specificity
  • Phosphotyrosine (metabolism)
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (enzymology, genetics, pathology)
  • Protein-Tyrosine Kinases (chemistry, metabolism)
  • RNA, Messenger (analysis, genetics)
  • Sequence Homology, Amino Acid
  • Signal Transduction
  • Stem Cells (enzymology, metabolism, pathology)
  • Transcriptional Activation
  • Translocation, Genetic (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: